Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. My name is [Martina Sarowitz]. I'm from the Growth Life Science Tools and Diagnostics team, part of Julia Qin's team. So it's my pleasure to introduce our next company, Myriad Genetics. Just as a reminder, following the presentation, we will have a Q&A session. (Operator Instructions) And with that, I will turn it over to Paul.
Great. Thank you, and thank the JPMorgan team for inviting us today. Obviously, it's great to be in person with everyone, and I want to thank everyone in our audience today and those online. I understand there may not be any Georgia fans in the crowd here, but thank you for coming today.
We're excited to give you an update and tell you about our plans for the future. First, I will remind you that we'll be making certain forward-looking statements and that you can find more information about us and our GAAP reconciliations on our website.
With that, it's been a busy couple of years. We've made a tremendous
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |